Everolimus for the treatment of refractory seizures associated with tuberous sclerosis complex (TSC): current perspectives

Overwater IE, Rietman AB, van Eeghen AM, de Wit MCY

Therapeutics and Clinical Risk Management 2019, 15:951-955

Published Date: 26 July 2019